Mitochondria are required for pro-ageing features of the senescent phenotype by Correia-Melo, Clara et al.
Article
Mitochondria are required for pro-ageing features
of the senescent phenotype
Clara Correia-Melo1,2, Francisco DM Marques1, Rhys Anderson1, Graeme Hewitt1, Rachael Hewitt3,
John Cole3, Bernadette M Carroll1, Satomi Miwa1, Jodie Birch1, Alina Merz1, Michael D Rushton1,
Michelle Charles1, Diana Jurk1, Stephen WG Tait3, Rafal Czapiewski1, Laura Greaves4, Glyn Nelson1,
Mohammad Bohlooly-Y5, Sergio Rodriguez-Cuenca6, Antonio Vidal-Puig6, Derek Mann7,
Gabriele Saretzki1, Giovanni Quarato8, Douglas R Green8, Peter D Adams3, Thomas von Zglinicki1,
Viktor I Korolchuk1 & João F Passos1,*
Abstract
Cell senescence is an important tumour suppressor mechanism
and driver of ageing. Both functions are dependent on the develop-
ment of the senescent phenotype, which involves an overproduc-
tion of pro-inflammatory and pro-oxidant signals. However, the
exact mechanisms regulating these phenotypes remain poorly
understood. Here, we show the critical role of mitochondria in
cellular senescence. In multiple models of senescence, absence of
mitochondria reduced a spectrum of senescence effectors and
phenotypes while preserving ATP production via enhanced glycoly-
sis. Global transcriptomic analysis by RNA sequencing revealed
that a vast number of senescent-associated changes are depen-
dent on mitochondria, particularly the pro-inflammatory pheno-
type. Mechanistically, we show that the ATM, Akt and mTORC1
phosphorylation cascade integrates signals from the DNA damage
response (DDR) towards PGC-1b-dependent mitochondrial biogene-
sis, contributing to a ROS-mediated activation of the DDR and cell
cycle arrest. Finally, we demonstrate that the reduction in mito-
chondrial content in vivo, by either mTORC1 inhibition or PGC-1b
deletion, prevents senescence in the ageing mouse liver. Our
results suggest that mitochondria are a candidate target for inter-
ventions to reduce the deleterious impact of senescence in ageing
tissues.
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Introduction
Cellular senescence, the irreversible loss of proliferative potential in
somatic cells, has been shown to not only play a major role in
tumour suppression, but also to contribute to age-related tissue
degeneration (Baker et al, 2011). While senescence can stably
repress cancer by irreversibly arresting damaged cells, senescent
cells have been shown to be detrimental in tissues, mainly by devel-
oping a complex senescence-associated secretory phenotype (SASP)
(Coppe´ et al, 2008; Kuilman & Peeper, 2009) and producing
elevated levels of reactive oxygen species (ROS) (Passos et al,
2010). These factors not only contribute to the maintenance of the
senescence arrest via self-amplifying positive feedback loops
(Acosta et al, 2008; Kuilman et al, 2008; Passos et al, 2010), but
can also induce senescence in healthy cells in a paracrine fashion
(Nelson et al, 2012; Acosta et al, 2013).
Mitochondria play an essential role in energy generation, cell
signalling, differentiation, death and senescence in eukaryotic cells.
Mitochondria’s role in cellular senescence is widely associated with
their significant role as generators of ROS-mediated random molecu-
lar damage. ROS have been shown to play important roles in senes-
cence by inducing genomic damage (Parrinello et al, 2003),
accelerating telomere shortening (von Zglinicki, 2002) and acting as
drivers of signalling networks important for the maintenance of the
senescent phenotype (Passos et al, 2010). However, other reports
have also highlighted the importance of non-mitochondrial ROS
sources (Takahashi et al, 2006), redox stress (Kaplon et al, 2013) or
deficits in antioxidant defence (Blander et al, 2003) in the develop-
ment of senescence. Therefore, it remains unknown whether mito-
chondria are truly necessary for senescence.
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To understand to what extent mitochondria are involved in
senescence, we took advantage of a recently identified process
whereby the depolarization of mitochondria by uncouplers, such as
CCCP, targets the ubiquitin ligase Parkin to mitochondria and
promotes their degradation via the proteasome and autophagy,
resulting in complete elimination of the mitochondrial compartment
(Narendra et al, 2008; Geisler et al, 2010). We found that wide-
spread targeted mitochondria depletion abrogates the development
of commonly described features of cellular senescence, such as the
pro-inflammatory and pro-oxidant phenotype and expression of the
cyclin-dependent kinase inhibitors p21 and p16, while preserving
the cell cycle arrest and therefore the tumour suppressor properties
of these cells. Furthermore, we delineate a mechanism by which the
DNA damage response (DDR), a major driver of senescence, inter-
acts with mitochondria to develop the senescent phenotype. We
demonstrate that the ATM, Akt and mTORC1 phosphorylation
cascade plays a key role as an effector of the DDR by promoting
PGC-1b-dependent mitochondrial biogenesis and cellular senescence
in vitro and in vivo.
Results
Mitochondria are key factors in the development of pro-ageing
features of senescence
To determine the importance of mitochondria for the establishment
and maintenance of cellular senescence, human MRC5 fibroblasts
were stably transduced with YFP-Parkin and senescence was
induced by X-ray irradiation (20 Gy) (Fig 1A). Parkin-mediated
mitochondrial clearance was confirmed by the absence of mitochon-
drial proteins (Fig 1B), the lack of mitochondrial respiration
and insensitivity to electron transport chain-inhibiting drugs (Fig 1C)
and the absence of intact mitochondria by 3D electron microscopy
(Fig 1D and Movies EV1 and EV2). This was observed not only
immediately after CCCP treatment, but also at later time points (up
to 16 days) after CCCP had been removed (Fig EV1A and B).
Elimination of mitochondria upon the induction of senescence
impacted on the development of specific effectors and phenotypes
of senescence. Mitochondria-depleted cells showed substantially
reduced cell size, Sen-b-Gal activity, the formation of heterochro-
matin foci, ROS generation and expression of the cyclin-dependent
kinase inhibitors p21 and p16 (Fig 1E–G). By conducting a cytokine
array, we found that the secretion of major SASP factors such as
IL-6, IL-8, GRO and MCP-1 was drastically reduced following mito-
chondrial clearance (Fig 1H). Independent ELISAs confirmed that
the secretion of the SASP components IL-6 and IL-8 was barely
detectable in the culture media of mitochondria-depleted senescent
cells (Fig EV1C). Similar results were observed in rho0 cells, which
are depleted of mtDNA and possess few petite mitochondria. Rho0
cells produced reduced levels of ROS and the pro-inflammatory
cytokine IL-6 in both basal conditions and during X-ray-induced
senescence (Fig EV1D).
Live-cell imaging of mitochondria-depleted cells for over 2 weeks
revealed cells displaying morphological features of non-senescent
fibroblasts (Movies EV3 and EV4). Mitochondria-depleted cells,
despite showing a slight increase in proliferation until 10 days, as
shown by a small rise in the percentage of Ki67-positive cells and
population doublings, had an extremely slow division rate (around
0.3 times that of young proliferating cells) and eventually stopped
dividing at 20 days post-induction of senescence (Fig EV1E).
Together with these observations, we found that mTOR activity, a
master regulator of cell growth and division, was decreased in senes-
cent mitochondria-depleted cells (Fig EV1F). Similar results were
observed in young proliferating cells, where the depletion of mito-
chondria resulted in decreased mTOR activity and impairment of cell
proliferation (Fig EV1G and H). Nevertheless, the cell cycle inhibi-
tion was not accompanied by the development of senescence-
associated alterations (Fig EV1H) or decreased ATP levels in the
young mitochondria-depleted cells (Fig EV1L).
In order to further understand the impact of mitochondria on
senescence, we performed RNA-seq analysis on proliferating (Prol),
senescent (Sen) and mitochondria-depleted senescent cells
(MDSen). Analysis of all genes that are differentially expressed
between Prol, Sen and MDSen showed that there was a tendency for
genes down-regulated in senescence to be up-regulated upon
mitochondrial depletion and for genes up-regulated in senescence to
be down-regulated upon mitochondrial depletion (Fig 2A). We
▸Figure 1. Mitochondria are key factors for the development of pro-ageing features of cellular senescence.A Scheme illustrating the experimental design: Parkin-expressing and control MRC5 fibroblasts were irradiated with 20-Gy X-ray and 2 days after were treated with
12.5 lM CCCP for 48 h. At day 4 after irradiation, CCCP was removed and cells were kept in culture with normal serum-supplemented medium. Cells were harvested
at days 10 or 20 after irradiation (6 or 16 days after CCCP treatment, respectively) for senescent phenotypes analysis.
B Western blots showing the absence of mitochondrial proteins from the different mitochondrial complexes: NDUFB8 (complex I), SDHA (complex II), UQCRC2 (complex III) and
MTCO-1 (complex IV), in senescent (10 days after 20-Gy X-ray) control and Parkin-expressing MRC5 fibroblasts. Data are representative of three independent experiments.
C Cellular oxygen consumption rates (OCR) in senescent (10 days after 20-Gy X-ray) control and Parkin-expressing MRC5 fibroblasts. Data were obtained using the
Seahorse XF24 analyzer and show mean  SD n = 4 technical repeats (representative of two independent experiments).
D Representative 3D EM pictures of senescent (20 days after 20-Gy X-ray) Parkin-expressing MRC5 fibroblasts with or without CCCP. Mitochondria are in red; the
nucleus in blue.
E Representative images of cell size, Sen-b-Gal activity (blue cytoplasmic staining), macro-H2A foci and SDHA immunofluorescence in proliferating and senescent
(10 days after 20-Gy X-ray) Parkin-expressing MRC5 fibroblasts. Scale bar = 10 lm.
F Quantification of ROS levels (DHE fluorescence), Sen-b-Gal-positive cells and senescence-associated heterochromatin foci (SAHF) observed by DAPI in proliferating
and senescent (10 days after 20-Gy X-ray) control and Parkin-expressing MRC5 fibroblasts. Data are mean  SEM of n = 3 independent experiments; asterisks denote
a statistical significance at P < 0.05 using one-way ANOVA.
G Representative Western blots showing p21 and p16 expression in proliferating and senescent (10 days after 20-Gy X-ray) control and Parkin-expressing MRC5
fibroblasts. Data are representative of 3 independent experiments.
H Secreted protein measured in a cytokine array (RayBiotech) of a variety of inflammatory proteins in proliferating and senescent (10 days after 20-Gy X-ray) Parkin-
expressing MRC5 fibroblasts. Data are mean  SEM of n = 3 independent experiments. Asterisks denote a statistical significance at P < 0.05 using one-way ANOVA.
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Figure 2. Global transcriptomic analysis reveals that mitochondria are significant contributors to the development of the senescent phenotype, particularly
the SASP.
A Column clustered heatmap showing all genes that are differentially expressed between proliferating (Prol), senescent (Sen) and mitochondria-depleted senescent
(MDSen) Parkin-expressing MRC5 fibroblasts (FDR ≤ 5%, absolute fold ≥ 2). Genes are by column and samples by row. The colour intensity represents column Z-score,
where red indicates highly and blue lowly expressed.
B Venn diagram showing the overlap of the differentially expressed genes (FDR ≤ 5%, absolute fold ≥ 2) between proliferating and senescent cells and between
senescent and MD senescent cells. Direction of change is indicated.
C Table of the 10 most significantly enriched (FDR ≤ 5%) gene ontologies for the “fully reversed” genes, as defined by the tool DAVID. Ontologies that are amongst the
10 most significantly enriched for genes that are significantly up-regulated between proliferating and senescent cells are indicated in red.
D Column clustered heatmaps of all SASP genes and cell cycle genes that are differently expressed in senescence; genes are by column and samples by row. The colour
intensity represents column Z-score, where red indicates highly and blue lowly expressed. SASP heatmap: genes that are labelled in green represent the 60% that are
fully reversed and genes labelled in pink represent the 5% that became exacerbated upon mitochondria clearance. Cell cycle heatmap: genes labelled in red are
significantly changed upon mitochondria clearance.
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observed that 41% of genes up-regulated in senescence are
down-regulated upon mitochondrial depletion (while only 6% are
up-regulated) and 33% of genes down-regulated in senescence
are up-regulated upon mitochondrial depletion (while only 4% are
down-regulated). In total, 38% of all senescent-associated changes
are reversed upon mitochondrial depletion (Fig 2B). Analysis of the
10 most significantly enriched (FDR ≤ 5%) Gene Ontologies (GO)
for the “fully reversed” genes, as defined by the tool DAVID include
“response to wounding”, “inflammatory response” and “biological
and cell adhesion” which comprise many of the SASP genes
(Fig 2C). In fact, by analysing specifically SASP components (Coppe´
et al, 2008), we found that the vast majority was down-regulated at
the mRNA level in mitochondria-depleted cells. 60% of the SASP
genes which are significantly different between proliferating and
senescent were reversed upon mitochondrial depletion, whereas
only 5% were exacerbated (Fig 2D). In contrast, analysis of genes
belonging to the GO term “cell cycle” showed generally no rescue
following mitochondrial clearance, with only a small subset of cell
cycle genes increasing at relatively low magnitude (Fig 2D).
One possibility to explain these observations would be that the
absence of mitochondria significantly impairs the cell’s energy
production capacity, thereby precluding the execution of the senes-
cence programme. In order to test this hypothesis, we analysed the
bioenergetics status of mitochondria-depleted cells. Analysis of the
extracellular acidification rate (ECAR) (Fig EV2A) confirms that
mitochondria-depleted senescent cells have a substantially increased
glycolytic rate when compared to controls; the addition of the
glucose uptake inhibitor 2-deoxyglucose (2DG) has a considerably
stronger effect in ECAR of mitochondria-depleted cells than in
controls (Fig EV2A). Furthermore, glycolysis-dependent ATP
production rate is greater in mitochondria-depleted senescent cells
than the ATP production rate driven collectively by both glycolysis
and OXPHOS in controls (Fig EV2B). Subsequent measurements of
steady-state cellular ATP levels confirmed that these were elevated
in mitochondria-depleted cells when compared to senescent controls
(Fig EV2C). Consistent with a reliance on glycolysis, glycolysis-
associated genes were generally up-regulated in mitochondrial-
depleted senescent cells (Fig EV2D). Together, these data suggest
that the failure to execute the senescence programme is not depen-
dent on ATP levels.
We next investigated whether mitochondrial clearance impacted
on other models of cellular senescence. Similar to X-ray-induced
senescence, clearance of mitochondria during oxidative stress-
induced senescence (Fig EV3A–C), oncogene-induced senescence
(Fig EV3D–F) and replicative senescence (Fig EV3G–J) reduced
markers of senescence.
Altogether, these data demonstrated that mitochondria are key
factors for the pro-oxidant and pro-inflammatory phenotypes. We
next sought to explore the mechanisms that regulate mitochondria
in cellular senescence.
PGC-1b-dependent mitochondrial biogenesis downstream of a
DDR modulates cellular senescence
Activation of a DDR is a prominent initiator of senescence during
stress-induced (Passos et al, 2010), replicative (d’Adda di Fagagna
et al, 2003) and oncogene-induced senescence (OIS) (Suram et al,
2012). In order to understand mitochondria regulation during
senescence, we tested the impact of DDR activators on mitochondrial
content in a variety of human and mice cell types. DDR activators
included X-ray irradiation, oxidative stress, DNA-damaging drugs and
telomere dysfunction. In all cases, we observed increased mitochon-
drial mass 2–4 days after DDR activation, suggesting that increased
mitochondrial content occurs downstream of a DDR, irrespective of
the stimuli (Appendix Fig S1A). Furthermore, mitochondrial mass
increased proportionally to the IR dose (Appendix Fig S1B) and
directly correlated with DNA damage foci, p21 expression and induc-
tion of Sen-b-Gal and inversely with the proliferation marker Ki67
(Appendix Fig S1C). These data indicate that mitochondrial mass
increase occurs downstream of a DDR and suggest that it may play a
role in the development of cellular senescence.
Corroborating the observation that mitochondrial content
increases downstream of a DDR, gene expression analysis showed
that the mitochondrial biogenesis transcriptional co-activators
PGC-1b and PGC-1a were up-regulated upon irradiation (Appendix
Fig S1D). We then proceeded to investigate whether the stimulation
of mitochondrial biogenesis could play a causative role in cellular
senescence. In order to directly evaluate the effect of mitochondrial
biogenesis on the induction of senescence, we used mouse embryonic
fibroblasts (MEFs) isolated from mice without the mitochondrial
biogenesis regulator PGC1-b. PGC-1b/ MEFs contained lower mito-
chondrial mass, mtDNA copy number and mitochondrial proteins
expression than wild-type MEFs in both basal conditions and follow-
ing exposure to senescence-inducing stimuli (Fig EV4A–C).
When cultured at normal atmospheric oxygen (21% O2), MEFs
acquire a senescent phenotype after a small number of passages,
while when grown at low oxygen (3% O2) MEFs show negligible
expression of senescence markers and divide at faster rates
(Parrinello et al, 2003). We found that at 21% oxygen, the absence
of PGC-1b delayed the senescence arrest as shown by colony assays
(Fig 3A). In wild-type MEFs, exposure to ambient oxygen or irradia-
tion impacted on the senescent phenotype shown by reduced
frequency of Ki67-positive cells, increased Sen-b-Gal activity and the
number of 53BP1 foci. All of these phenotypes could be delayed in
the absence of PGC-1b (Fig 3B and C). Furthermore, we found that
mRNA expression of the senescence-associated genes p16 and
CXCL1 was significantly reduced in PGC-1b/ MEFs following the
induction of senescence by X-ray irradiation (Fig 3D). Similar
results were observed in human fibroblasts using a shRNA against
PGC-1b (Fig EV4D–F).
In contrast, overexpression of PGC-1b (Fig EV4G and H) led to
the loss of proliferative capacity and increased Sen-b-Gal activity and
frequencies of 53BP1 foci both in proliferating and in IR-induced
senescent fibroblasts (Fig 3E). Overexpression of PGC-1b resulted in
a significant increase in mitochondrial mass both in basal conditions
and during senescence (Figs 3E and EV4I). Together, these data indi-
cate that mitochondrial mass increases following a DDR and estab-
lishes a causal relationship between mitochondrial biogenesis and
senescence. We then proceeded to explore the signalling pathways
linking the DDR to mitochondrial biogenesis.
ATM, Akt and mTORC1 integrate DDR signalling towards
mitochondrial biogenesis during cellular senescence
The mammalian target of rapamycin (mTOR) pathway has been
widely implicated in processes governing mitochondrial turnover.
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mTOR complex 1 (mTORC1) has been shown to integrate stress
signals into the regulation of protein and lipid synthesis and auto-
phagy, all of which are involved in the complex pathways mediating
mitochondrial homeostasis (Laplante & Sabatini, 2012).
Following the induction of a DDR using X-ray irradiation, human
fibroblasts show a progressive increase in phosphorylation of the
mTORC1 target p70S6K (Fig 4A). Consistent with a role for
mTORC1 in DDR-dependent mitochondrial protein expression,
expression of mitochondrial proteins belonging to the OXPHOS
complexes I, II, III and IV (NDUFB8, SDHA, UQCRC2 and MT-CO1)
and TOMM20 were significantly reduced by rapamycin treatment, a
mTORC1 inhibitor (Fig 4B and Appendix Fig S2A). To test the
robustness of our findings, we screened mitochondrial mass as
before following treatment with known DDR activators in a variety
of human and mouse cell types. In all cases, the increased mito-
chondrial mass was invariably reduced by rapamycin (Fig 4C). This
effect was confirmed at the level of mitochondrial volume fraction
and numbers by transmission electron microscopy (T.E.M.), mtDNA
copy number (Fig 4D) and live-cell MitoTracker staining in human
fibroblasts (Appendix Fig S2B). Comparable effects were observed
in MEFs following stress-induced senescence (Appendix Fig S2C).
mTORC1 inhibition also repressed the expression of PGC-1a and
PGC-1b genes and the downstream OXPHOS genes ATP5G1, COX5A
and NDUFS8 (Appendix Fig S2D and E). In contrast, mTORC1 acti-
vation via overexpression of constitutively activate mutated Rheb
(N153T) (Urano et al, 2007) resulted in increased mitochondrial
mass in non-stressed cells (Appendix Fig S2F).
Previous studies have suggested links between the DDR and the
mTOR signalling pathway potentially via protein kinase B (PKB/
Akt) phosphorylation: firstly, Akt has been shown to activate
mTORC1 by directly phosphorylating the TSC1/TSC2 complex
(Inoki et al, 2002) or by dissociation of PRAS40 from the essential
mTORC1 component RAPTOR (Thedieck et al, 2007). Secondly,
Akt has been shown to be a direct phosphorylation target of ATM,
an upstream driver of the DDR (Viniegra et al, 2005). To test the
relation between ATM, Akt and mTORC1, we induced a DDR in
human fibroblasts by X-ray irradiation and treated them with an
ATM inhibitor. ATM inhibition reduced Akt (S473) and p70S6K
(T389) phosphorylation and expression of the cyclin-dependent
kinase inhibitor p21 and the mitochondrial protein NDUFB8
following activation of the DDR when compared to controls (Fig 4E
and F). We confirmed these observations on human fibroblasts
derived from an ataxia telangiectasia (AT) patient, which have
impaired ATM signalling (Fig 4E). In support of a pathway
involving ATM, Akt and mTORC1 in mitochondrial mass regula-
tion, chemical inhibition of ATM and mTORC1 activity reduced
mitochondrial mass with no additive effect when both inhibitors
were applied simultaneously (Fig 4G). Our data indicate a novel
pathway linking the DDR and mitochondria via the ATM, Akt and
mTORC1 phosphorylation cascade and transcriptional activation of
mitochondrial biogenesis.
mTORC1-PGC-1b-dependent mitochondrial biogenesis maintains
ROS-driven DNA damage foci (DDF) and contributes to the
senescent phenotype
Cumulative data suggest that persistence of a DDR is a key factor in
the maintenance of the irreversible arrest observed during cellular
senescence. We have previously reported that a significant fraction
of the DNA damage foci (DDF) remain unrepaired during cellular
senescence and may be a consequence of ROS-generated DNA
damage (Passos et al, 2010). For these reasons, we decided to inves-
tigate the links between mTORC1, mitochondrial biogenesis and the
stabilization of a DDR.
mTORC1 inhibition, by rapamycin supplementation, following
X-ray irradiation decreased DDF in human and mouse fibroblasts
(Fig EV5A and B). Similar effects were observed when exposing
cells to DNA-damaging agents such as etoposide, neocarzinostatin
(NCS) and hydrogen peroxide (H2O2) (Fig EV5B). Furthermore,
inhibition of mTORC1 resulted in decreased p21 mRNA and protein
expression (Fig EV5C).
To test whether ROS and DDF were driven by mTOR, we first
knocked down mTOR using siRNA (Fig EV5D) and found that it
reduced both ROS and DDF in senescent fibroblasts (Fig 5A).
Furthermore, senescent cells supplemented with both rapamycin
and the antioxidant NAC showed no cumulative reduction in both
ROS and DDF (Fig 5B). Consistent with previous data confirming a
central role for a persistent DDR in the development of senescence
and the emergence of the SASP (Rodier et al, 2009; Hewitt et al,
2012), we found that (i) mTORC1 inhibition significantly reduced
frequencies of Sen-b-Gal-positive cells in various models of stress-
induced and replicative senescence (Fig EV5E) without rescuing the
cell cycle arrest (Fig EV5F) and (ii) mTORC1 inhibition suppressed
senescence-associated secretion of several pro-inflammatory cyto-
kines (Fig EV5G). Further supporting the hypothesis that ATM and
mTORC1 are downstream effectors of the DDR regulating senes-
cence, both mTORC1 and ATM inhibition resulted in decreased
mRNA expression of the SASP factor IL6 (Fig EV5H) and mTORC1
▸Figure 3. PGC-1b-dependent mitochondrial biogenesis downstream of the DDR modulates cellular senescence.A Representative images of colony assays of wild-type and PGC-1b/ MEFs grown at 3 or 21% O2 (10 days after seeding 5,000 cells per well). Data are representative of
3 independent experiments.
B Effect of 3 or 21% O2 and X-ray irradiation (at 3% O2) on the percentage of Ki67 (at day 6) and Sen-b-Gal-positive cells (at day 10) and the number (N) of 53BP1 foci
(at day 6) in wild-type and PGC-1b/ MEFs. Data are mean  SEM of n = 3 independent experiments; asterisks denote a statistical significance at P < 0.05 using
one-way ANOVA.
C Representative images of Sen-b-Gal activity (blue cytoplasmatic staining), Ki-67 and 53BP1 foci in proliferating and senescent wild-type and PGC-1b/ MEFs (scale
bar = 10 lm).
D mRNA expression of PGC-1b, CXCL-1 and p16 in proliferating and senescent (10 days after 10-Gy X-ray) wild-type and PGC-1b/ MEFs. Data are mean  SEM of
n = 3 independent experiments; asterisks denote a statistical significance at P < 0.05 using one-way ANOVA.
E Effects of overexpression of PGC-1b on percentage of Ki67- and Sen-b-Gal-positive cells, number (N) of 53BP1 foci and percentage change in mitochondrial mass
(NAO intensity) in proliferating and senescent (2 days after 10-Gy X-ray) MEFs cultured at 3% O2. Data are mean  SEM of n = 3 independent experiments. Asterisks
denote a statistical significance at P < 0.05 using one-way ANOVA or two-tailed t-test.
The EMBO Journal ª 2016 The Authors
The EMBO Journal Mitochondria drive senescence Clara Correia-Melo et al
6
Published online: February 4, 2016 
01
2
3
4
5
6
0
1
2
3
4
5
*
*
*
0
4
8
12*
3%O2      21%O2       
*
3%O2         3%O2 (Sen IR)      
*
*
21% O2
N.D. N.D.
0
30
60
0
6
12*
*
*
0
140
280
*
*
0
60
30
*
*
3%O2          3%O2 (Sen IR)             3%O2           3%O2 (Sen IR)
C
E
3% O2
3%O2      21%O2              
3%O2          3%O2 (Sen IR)             3%O2           3%O2 (Sen IR)        
B
     Sen-β-Gal                Ki67             53BP1
 Prol      Sen (IR)
D
   
   
  w
t
* *
3%O2      21%O2          
wt
PGC-1β -/-
wt
PGC-1β -/-
P
G
C
-1
β 
-/-
 Prol      Sen (IR)  Prol      Sen (IR)
pcDNA
pcDNA-f: PGC-1β
3%O2  (Sen IR)     3%O2  (Sen IR)     
A
wt
PGC-1β -/-
3%O2  (Sen IR)     
p1
6
CX
CL
1
PG
C-1
β
p1
6
CX
CL
1
PG
C-1
β
80
60
40
20
0
80
60
40
20
0 0
10
20
30
40
50
70
60
0
10
20
30
40
50
70
60
%
 K
i6
7 
%
 S
en
-β
-G
al
N
 5
3B
P
1 
fo
ci
%
 K
i6
7 
N
 5
3B
P
1 
fo
ci
%
 S
en
-β
-G
al
%
 M
ito
 M
as
s
m
R
N
A 
(F
C
)
Figure 3.
ª 2016 The Authors The EMBO Journal
Clara Correia-Melo et al Mitochondria drive senescence The EMBO Journal
7
Published online: February 4, 2016 
and ATM inhibition had non-additive effects on DDF, induction of
Sen-b-Gal and p21 expression (Fig 5C).
To investigate the role of mitochondria biogenesis on ROS-
dependent activation of a DDR, we used PGC-1b/ MEFs. We hypo-
thesized that PGC-1b-mediated mitochondrial biogenesis increases
oxidative stress, thereby activating senescence-associated pathways.
Consistently, we found that exposure to irradiation increased ROS
generation in wild-type MEFs and this was markedly reduced in
PGC-1b/ MEFs. In contrast, overexpression of PGC-1b resulted in
increased ROS (Fig 5D) and treatment with the antioxidant Trolox
prevented PGC-1b-induced DNA damage measured by frequencies
of 53BP1 foci (Fig 5E), suggesting that the mitochondrial biogenesis
inducer PGC-1b potentiates oxidative stress and the senescent
phenotype. To investigate the role of PGC-1b in mTORC1 signalling
downstream of a DDR, we increased or decreased mTORC1 activity
in wild-type and PGC-1b/ MEFs by the overexpression of activated
Rheb (Fig EV5I) or rapamycin supplementation, respectively.
Following the activation of a DDR, the Rheb-dependent increase in
the number of DDF was suppressed in PGC-1b/ MEFs and rapa-
mycin treatment was unable to further decrease DDF in PGC-1b/
MEFs (Fig 5F), suggesting that mTORC1 and PGC-1b are part of the
same pathway leading to mitochondrial ROS-dependent mainte-
nance of a DDR. Consistent with our data that mTORC1-PGC1b-
mediated mitochondrial biogenesis promotes senescence, mTORC1
inhibition by rapamycin decreased Sen-b-Gal activity in wild-type
MEFs, but had no further effect in PGC-1b/ senescent MEFs
(Fig EV5J).
Together, these observations suggest that maintenance of the
DDR via mTORC1-PGC-1b-driven mitochondrial biogenesis impacts
on the development of cellular senescence and the SASP.
mTORC1-PGC-1b regulates mitochondrial content and
contributes to senescence in vivo
Following our in vitro observations showing a DDR-dependent
mitochondrial mass increase during senescence, we first asked
whether mitochondrial abundance would correlate with the activa-
tion of a DDR in vivo. To address that, we performed dual
immunofluorescence against the mitochondrial protein MT-CO1 and
the DDR protein cH2A.X in liver tissue from 12-month-old mice. We
observed that hepatocytes containing more MT-CO1 intensity had
in general higher number of cH2A.X foci (Fig 6A). Secondly, we
investigated whether the DDR-dependent activation of the mTORC1-
PGC-1b pathway and increased mitochondrial content occur with
age in vivo. Similar to our observations in vitro, we found an age-
dependent increase in PGC-1b expression and OXPHOS components
associated with increased mTORC1 activity (measured by p-S6/S6
ratio) and p21 expression in wild-type mice (Fig 6B and
Appendix Fig S3A). Similar to fibroblast senescence, hepatocyte
senescence seems to be associated with increased mitochondrial
mass, mTORC1 activity and increased DDR signalling.
To investigate the impact of mTORC1 inhibition on mitochon-
drial mass in vivo, mice were fed with rapamycin using the same
conditions as Harrison et al (2009) and sacrificed at different ages
(Appendix Fig S3B). Rapamycin-supplemented animals presented
reduced PGC-1b protein expression (Fig 6C), lowered mitochondrial
volume fraction and mitochondrial numbers per cross-section (anal-
ysed by T.E.M.) (Fig 6D) and decreased mtDNA copy number
(Fig 6E) when compared to controls. We also investigated whether
mTORC1 inhibition impacted on mitochondrial function by poten-
tially mediating the clearance of dysfunctional mitochondria.
Mitochondrial function analysis showed no significant changes
between control and rapamycin-supplemented animals. State III
(ADP-stimulated), state IV and respiration uncoupled from ATP
synthesis (using the uncoupler FCCP) remained unchanged using
pyruvate/malate as substrate (Fig 6F). These results indicate that
despite lower mitochondrial content in hepatocytes, mitochondrial
function is not significantly altered by mTORC1 inhibition. Recently,
it has been suggested that rapamycin may reduce ROS generation
via enhanced expression of the antioxidant enzyme MnSOD
(Iglesias-Bartolome et al, 2012), however, we failed to find any
changes in MnSOD expression on rapamycin-fed mice liver tissues
(Appendix Fig S3C).
We next questioned whether mTORC1 inhibition could reduce
senescence markers, similar to what we had observed in vitro. We
had previously reported that telomere-associated foci (TAF), one of
▸Figure 4. mTORC1 integrates DDR signals towards mitochondrial biogenesis during cellular senescence.A Representative Western blot of mTORC1 activity measured by phosphorylated p70S6K (T389) from 6 to 72 h after 20 Gy in MRC5 fibroblasts. Data are representative
of three independent experiments.
B Representative Western blots of the mitochondrial proteins TOMM20, NDUFB8 (complex I), SDHA (complex II), UQCR2 (complex III) and MT-CO1 (complex IV)
following 20-Gy irradiation with or without 100 nM rapamycin treatment in MRC5 fibroblasts. Data are representative of 4 independent experiments.
C Effect of 100 nM rapamycin on mitochondrial mass (measured by NAO fluorescence) 2–4 days following replication exhaustion (RS), genotoxic stress (generated by
X-ray irradiation, etoposide, neocarzinostatin (NCS), H2O2) or telomere dysfunction (TRF2
DBDM) in a variety of cell lines. Data are mean from 3 independent
experiments per cell line or treatment.
D (top) Representative transmission electron microscopy (T.E.M.) micrographs of proliferating and senescent (3 days after 20-Gy X-ray) MRC5 fibroblasts treated with or
without 100 nM rapamycin. Mitochondria are labelled in pink. Scale bar = 2 lm; (bottom left and middle) Quantification of mitochondrial volume fraction (%Vv) and
mitochondrial number per cross-section in proliferating and senescent (3 days after 20-Gy X-ray) MRC5 fibroblasts treated with or without 100 nM rapamycin. T.E.M.
mitochondrial analysis is mean  SEM of 24 electron micrographs per condition; (bottom right) mtDNA copy number analysis by qPCR in proliferating and senescent
(3 days after 20-Gy X-ray) MRC5 fibroblasts treated with or without 100 nM rapamycin. Data are mean  SEM of n = 3 independent experiments; asterisks denote a
statistical significance at P < 0.05 using one-way ANOVA.
E Representative Western blots showing the expression of phosphorylated p70S6K (T389) and AKT (S473), the mitochondrial protein NDUFB8 and the DDR downstream
target p21 in MRC5 fibroblasts treated with or without 10 lM of the ATM inhibitor KU55933 and in fibroblasts from a patient with ataxia telangiectasis (AT) at
different time points after 20-Gy X-ray. Data are representative of three independent experiments (ATM inhibitor) and 1 experiment (AT patient).
F Western blots showing the effect of the ATM inhibitor KU55933 on cH2A.X, AKT phosphorylation and p21 expression in MRC5 fibroblasts after 20-Gy X-ray. Data are
from one experiment.
G Effect of rapamycin and/or ATM inhibitor (KU55933) on mitochondrial mass (NAO intensity) in proliferating and senescent (3 days after 20-Gy X-ray) MRC5 fibroblasts.
Data are mean  SEM of n = 3 independent experiments. Asterisks denote a statistical significance at P < 0.05 using one-way ANOVA.
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the important effectors of cellular senescence, increase with age in
wild-type mice tissues and in models of accelerated ageing (Hewitt
et al, 2012; Jurk et al, 2014). In order to test the impact of mTORC1
inhibition on telomere-induced senescence in vivo, we analysed
liver tissue from rapamycin-fed mice and showed that mTORC1
inhibition was able to prevent age-dependent increase in TAF
(Fig 6G). Interestingly, 4 months of rapamycin-supplemented diet
was as effective in reducing TAF as 12 months (Fig 6G). Moreover,
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Figure 5. mTORC1 activation promotes ROS-dependent DDR and contributes to the senescent phenotype via PGC1-b dependent mitochondrial biogenesis.
A ROS levels (DHE intensity) and mean number (N) of cH2A.X foci after mTOR knockdown (72 h) in proliferating and senescent (2 days after 20-Gy X-ray) MRC5
fibroblasts. Data are mean  SEM of n = 3 independent experiments; asterisks denote a statistical significance at P < 0.05 using one-way ANOVA.
B ROS levels (DHE intensity) and mean number (N) of cH2A.X foci in proliferating and senescent (3 days after 20-Gy X-ray) MRC5 fibroblasts treated with or without
100 nM rapamycin and/or 2.5 mM of the antioxidant NAC. Data are mean  SEM of n = 3 independent experiments; asterisks denote a statistical significance at
P < 0.05 using one-way ANOVA.
C (top) Scheme illustrating the experimental design: human MRC5 fibroblasts were irradiated with 20-Gy X-ray and treated at day 3 after IR with 10 lM of the ATM
inhibitor (ATMi) KU55933 and/or 100 nM rapamycin (Rap); (bottom) Effect of single or combined inhibition of ATM and mTORC1 on the mean number (N) of cH2A.X
foci, Sen-b-Gal activity and p21 expression in proliferating and senescent (10 days after 20-Gy X-ray) MRC5 fibroblasts. Data are mean  SEM of n = 3 independent
experiments. Western blots are representative of three independent experiments; asterisks denote a statistical significance at P < 0.05 using one-way ANOVA.
D ROS levels (DHE intensity) in proliferating and senescent (3 days after 10-Gy X-ray) wild-type and PGC-1b/ MEFs (top) and PGC-1b-overexpressing MEFs (bottom).
Data are mean  SEM of n = 3 independent experiments; asterisks denote a statistical significance at P < 0.05 using one-way ANOVA.
E (top) Representative images and quantification of immunofluorescence staining against FLAG-PGC-1b (red) and 53BP1 (green) in PGC-1b-overexpressing MEFs
cultured at 3% O2, with or without 250 lM of the antioxidant Trolox (scale bar = 10 lm). Data are mean  SEM, n = 3 independent experiments; asterisks denote a
statistical significance at P < 0.05 using one-way ANOVA.
F (top) Effect of overexpression of mutated Rheb (N153T) and (bottom) effect of 100 nM rapamycin on the mean number (N) of 53BP1 foci in proliferating and
senescent (3 days after 10-Gy X-ray) wild-type and PGC-1b/ MEFs. Data are mean  SEM of n = 3 independent experiments (at least 125 cells were analysed per
condition). Asterisks denote a statistical significance at P < 0.05 using one-way ANOVA.
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TAF could not be attributed to changes in telomere length or telom-
erase activity (Appendix Fig S3D and E). Consistent with a role for
mTORC1 in senescence in vivo, we observed (i) decreased Sen-b-Gal
activity, with Sen-b-Gal-positive hepatocytes being generally positive
for TAF (Fig 6H), (ii) reduced expression of the cyclin-dependent
kinase inhibitor p21 (Fig 6I) and (iii) diminished SASP factors
expression (Fig 6J) in the liver tissue of rapamycin-fed animals.
In order to test in vivo whether the expression of PGC-1b would
have an impact on senescence, we analysed the liver tissue from
aged PGC-1b/mice. PGC-1b/mice showed reduced mtDNA copy
number, mitochondrial proteins in liver tissue and lower energy
expenditure than wild-type littermates (Appendix Fig S3F). Consis-
tent with our hypothesis that mitochondrial content impacts on DDR
and our data revealing a role for PGC-1b in senescence in vitro, we
found reduced senescent markers such as TAF (Fig 6K) in PGC-1b/
mice. The absence of PGC-1b also ameliorated age-dependent
decline in glucose and insulin tolerance (Appendix Fig S3G). Similar
to rapamycin-fed mice, we did not find any changes in MnSOD
expression in PGC-1b/ mice liver tissues (Appendix Fig S3H).
Altogether, our data strongly support a causal link between the DDR,
mTORC1 and mitochondrial mass increase in the development of
senescence in vitro and in vivo (Fig 6L).
Discussion
Mitochondria have been widely associated with cellular senescence
and ageing. While pharmacological interventions reducing ROS
generation have been proven to be beneficial, it is unclear whether
mitochondria are required for senescence. ROS derived from non-
mitochondrial sources (Takahashi et al, 2006) and imbalances in
antioxidant defence (Blander et al, 2003) have equally been impli-
cated in the process. Chemical and genetic interventions impacting
on the mitochondrial electron transport chain have been shown to
enhance OIS (Moiseeva et al, 2009); however, to date, no study has
effectively evaluated the necessity of mitochondria for the induction
of the senescent phenotype. In order to investigate the role of mito-
chondria in senescence, we used a similar approach to recent explo-
rations of the mechanisms underlying cell death (Tait et al, 2013).
By targeted depletion of mitochondria, we demonstrate that these
organelles are key factors for the development of major ageing-
promoting characteristics of the senescent phenotype, including the
pro-oxidant and pro-inflammatory phenotypes, but less so for the
proliferation arrest despite increased glycolysis and ATP generation.
It is still unclear what is the mechanism contributing to the mainte-
nance of the proliferation arrest. We speculate that a multitude of
factors including the production of specific growth-stimulating mito-
chondrial metabolites or interactions between mitochondria and
cytoplasmic elements required for cell division may underlie the
process (Mitra et al, 2009). The interplay between mitochondria
and the mTOR signalling pathway may also be involved in this
process, since we have shown that mitochondria clearance reduces
mTOR activity and inhibition of mTOR activity inhibits proliferation
contributing to quiescence. Recent studies have also shown that the
mechanisms by which mTOR impacts on the cell cycle are uncou-
pled from its effect on the SASP (Herranz et al, 2015; Laberge et al,
2015). While we acknowledge that mitochondrial ablation is a dras-
tic intervention with possible widespread consequences for the cells,
Figure 6. mTORC1-PGC-1b regulates mitochondrial content and contributes to senescence in vivo.
A (top) Representative image of immunofluorescence double staining for the mitochondrial protein MT-CO1 and the DDR marker cH2A.X (scale bar = 5 lm) and
(bottom) quantification of MT-CO1 intensity versus the number of cH2A.X foci in hepatocytes from 12-month-old mice. Data are mean  SEM of n = 3 mice (at least
30 cells were analysed per mouse); asterisks denote a statistical significance at P < 0.05 using one-way ANOVA.
B Representative Westerns blots of pS6, S6, p21, PGC-1b, MT-CO1 and NDUFB8 protein expression in mouse liver tissue at 3 and 12 months of age. Data are from n = 3
mice per group.
C Effect of 4 months of rapamycin-supplemented diet on PGC-1b expression in the liver tissue of 16-month-old mice. Data are from n = 3 mice per group.
D (top) Quantification of mitochondrial number per cross-section and mitochondrial volume fraction (%Vv) in hepatocytes from 16-month-old mice with or without
4 months of rapamycin diet. Data are mean  SEM of n = 3 mice per group (at least 20 cells were analysed per mouse); (bottom) Representative electron
micrographs of hepatocytes from 16-month-old mice with or without 4 months of rapamycin diet (mitochondria are labelled in pink). Scale bar = 5 lm. Asterisk
denotes a statistical significance at P < 0.05 using two-tailed t-test.
E mtDNA copy number (measured by qPCR) in mice liver tissue at 3, 12, 16 months and at 16 months after 4 months of rapamycin diet. Data are mean  SEM of
n = 3–4 mice per group; Asterisks denote a statistical significance at P < 0.05 using one-way ANOVA.
F Oxygen consumption rates (OCR) in isolated liver mitochondria from 16-month-old mice fed with or without rapamycin for 4 months, in the presence of
pyruvate/malate. State III was induced by the injection of ADP. State IV was induced by the inhibition of the ATP synthase with oligomycin, and uncoupled respiration
rates were determined by the injection of FCCP. Antimycin A (AA) was used to determine background, non-mitochondrial OXPHOS, OCR. Data are mean  SEM of
n = 5 mice per group.
G (top) Representative immuno-TeloFISH images of hepatocytes from 3- and 15-month-old mice with or without rapamycin (12-month diet). Co-localizing foci are
amplified in the right panel (amplified images are from single Z-planes where co-localization was found); (bottom) Dot plot graph of telomere-associated foci (TAF) in
3-, 15- and 16-month-old mice (15- and 16-month-old mice were fed with rapamycin for 12 and 4 months, respectively). Data are from n = 3 to 9 mice per group (at
least 50 cells were analysed per mice). Values are the mean for individual animals, with the horizontal line representing group mean. Asterisk denotes P < 0.05 using
an independent samples t-test.
H (top) 4-month-old and 15-month-old mice livers [control () or rapamycin (+)] stained with Sen-b-Gal solution (Sen-b-Gal activity is evidenced by blue staining).
Data are from n = 3 mice per group; (bottom) Representative image showing Sen-b-Gal staining (Sen-b-Gal activity is evidenced by blue staining) in hepatocytes and
corresponding immuno-TeloFISH (arrows represent co-localizing foci); asterisks denote a statistical significance at P < 0.05 using one-way ANOVA.
I Representative Western blot showing the effect of 4-month rapamycin feeding on p21 expression in 16-month-old mice. Data are from n = 3 mice per group.
J Effect of 4-month rapamycin feeding on mRNA expression of the SASP components CXCL1, CXCL5 and inhibin A in liver tissue of 16-month-old mice. Data are from
n = 5 mice per condition; asterisks denote a statistical significance at P < 0.05 using two-tailed t-test.
K Mean number of TAF in hepatocytes of wild-type and PGC-1b/ mice with 18 months of age. Data are mean  SEM of n = 4 mice per group; asterisks denote a
statistical significance at P < 0.05 using two-tailed t-test.
L Scheme represents overall hypothesis: feedback loop between DDR, mTORC1 and mitochondrial biogenesis stabilizes cellular senescence, which are key factors for the
development of the senescence-associated pro-oxidant and pro-inflammatory phenotypes.
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our results demonstrate that mitochondria play a central role in
many of the transcriptional changes observed during senescence,
particularly the SASP, and have, as such, a great therapeutic
potential.
Furthermore, we have identified a novel pathway involving
ATM, Akt, mTORC1 and PGC-1b in the induction of senescence.
Although we do not exclude the existence of alternative pathways
impacting on mitochondrial content during senescence, such as
impaired mitophagy, our results establish a novel link between the
activation of a DDR and mitochondrial biogenesis involving the
mTORC1 signalling cascade. While mTORC1 has previously been
implicated in senescence (Pospelova et al, 2012), the mechanisms
regulating its activation as well as its links to the pro-oxidant and
pro-inflammatory features of the phenotype are still unclear. Two
recent studies have shown that mTOR inhibition suppressed the
senescence-associated secretion of inflammatory cytokines by
suppressing the translation of SASP regulatory proteins IL-1A and
MK2 (Herranz et al, 2015; Laberge et al, 2015). On the other hand,
our data show that interventions targeting the mTOR pathway affect
the maintenance of a DDR via the generation of ROS, which has
been shown to be necessary for the induction of senescence and the
SASP (Rodier et al, 2009; Passos et al, 2010). Our findings are
consistent with a model by which mTORC1 signalling impacts on
mitochondria content and by doing so, affects the persistence of a
DDR and the development of the SASP. We cannot disregard,
however, direct modes of interaction between mTORC1 and targets
of the DDR such as p53, independently of mitochondria (Lee et al,
2007; Lai et al, 2010). While these studies report dynamic interac-
tions between the mTOR and p53 pathways very shortly after a
DDR, they do not explain how the cell cycle arrest is maintained
and contributes to the development of senescence, which is a
lengthier process usually taking between 7 and 10 days post-DDR
activation (Coppe´ et al, 2008). While both our data and others indi-
cate the links between DDR activation and the SASP (Rodier et al,
2009; Osorio et al, 2012), it is possible that alternative mechanisms
play a role in the process, given reported direct interactions between
mTOR signalling, mitochondria and major SASP regulators such as
the NF-jB pathway (Correia-Melo et al, 2014).
Our in vivo data are consistent with reports in haematopoietic
stem cells in which mTORC1 activity increases mitochondrial
biogenesis, contributing to ROS-dependent decreased stemness and
haematopoiesis (Chen et al, 2008), and that mTOR inhibition can
alleviate mitochondrial disease (Johnson et al, 2013). Furthermore,
the observation of a key role for mTORC1 in vivo in the mainte-
nance of a DDR is supported by reports that calorie restriction (CR),
which impacts on mTORC1 activity, reduces DDR-positive cells
in vivo in several tissues (Wang et al, 2010; Jurk et al, 2012) as
well as ROS (Lanza et al, 2012). Our observations of reduced
mitochondrial content in hepatocytes following mTORC1 inhibition
are in accordance with various reports of reduced protein synthesis
and mitochondrial transcriptional regulation observed in mice with
impaired mTORC1 activity (Cunningham et al, 2007; Romanino
et al, 2011). Moreover, it has been recently shown by whole-
genome expression profiling and large-scale proteomic analysis
that mice under CR have less mitochondrial protein synthesis
(Lanza et al, 2012). This latter study, together with other more
recent reports (Hancock et al, 2011; Lanza et al, 2012; Price et al,
2012), has questioned early associations between CR and
enhanced mitochondrial content (Nisoli et al, 2005). Furthermore,
despite evidence suggesting that increased mitochondrial abun-
dance can be an advantageous adaptive response to energy
deficit, genetically induced mitochondrial biogenesis has been
associated with age-related diseases such as cardiomyopathy
(Lehman et al, 2000), renal fibrosis (Hickey et al, 2011) and
diabetes (Sawada et al, 2014), all of which have been associated
with cellular senescence (Chimenti et al, 2003; Sone & Kagawa,
2005; Ning et al, 2013).
Age-dependent mitochondrial degeneration has been associated
with impaired clearance of dysfunctional mitochondria, a process
known to be negatively regulated by mTORC1. Nonetheless, our
data show that rapamycin leads to no significant changes in the
function of isolated mitochondria from liver, which has been inde-
pendently confirmed (Johnson et al, 2013; Miwa et al, 2014),
despite reducing DNA damage, senescence markers and ROS gener-
ation. Our data suggest that mTORC1-dependent enhanced mito-
chondrial content may be impacting on ageing-promoting features
of senescence in vivo without necessarily affecting mitochondrial
function; however, further detailed studies on the role of mTOR
signalling on mitochondrial function and the mechanisms
underlying ROS generation are clearly warranted.
There is great interest in therapeutically combating the pro-
oxidant and pro-inflammatory effects of cellular senescence, given
their suggested role as drivers of age-related diseases (Tchkonia
et al, 2013; Correia-Melo et al, 2014). Our observations demonstrat-
ing that mitochondria are required for these features of senescence
have very important implications for our understanding of the
origins and mechanisms underlying the senescence phenotype and
suggest mitochondria as major putative therapeutic targets for inter-
ventions impacting on the senescent phenotype, while maintaining
its tumour suppressor capability.
Materials and Methods
Cell culture
Human embryonic lung MRC5 fibroblasts, human embryonic
kidney HEK293, human breast cancer MCF7, human primary
glioblastoma U87, human colon carcinoma HCT116, human
primary BJ fibroblasts, Phoenix amphotropic cells, AT patient
fibroblasts, T19 and HeLa cells were grown in Dulbecco’s modified
Eagle’s medium (DMEM, Sigma, Dorset, UK) supplemented with
10% heat-inactivated foetal calf serum (FCS), 100 units ml1 peni-
cillin, 100 lg ml1 streptomycin and 2 mM glutamine at 37°C in a
humidified atmosphere with 5% CO2. Human 143B parental and
rho0 osteosarcoma cells were grown in Dulbecco’s modified Eagle’s
medium (DMEM, Sigma, Dorset, UK) supplemented with 10% heat-
inactivated foetal calf serum (FCS), 100 units ml1 penicillin,
100 lg ml1 streptomycin, 2 mM glutamine, 50 lg ml1 uridine
and 0.11 mg ml1 sodium pyruvate at 37°C in a humidified atmo-
sphere with 5% CO2. T19 cells containing a doxycycline-inducible
TRF2DBDM were a kind gift from T. de Lange, Rockefeller University,
NY, USA (van Steensel et al, 1998). AT patient fibroblasts were a
kind gift from Dr. Lisa Woodbine, University of Sussex, UK.
Mouse embryonic fibroblasts (MEFs) were obtained from C57/
BL6 wild-type mice. MEFs from PGC-1b/ and matched wild-type
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mice were cultured in advanced DMEM/F-12 (Invitrogen) plus 10%
FSC, 100 units ml1 penicillin, 100 lg ml1 streptomycin and
2 mM glutamine at 37°C in a humidified atmosphere with 5% CO2
and 3% oxygen in a 3-gas cell culture incubator (Zapf Instruments,
Sarstedt, Germany). Cells were regularly checked for mycoplasma
contamination.
Induction of senescence
Stress-induced senescence was induced by X-ray irradiation with 10
or 20 Gy (depending on cell line), neocarzinostatin (80 ng ml1) for
1 h and H2O2 (400 lM) in serum-free media for 1 h. Following
treatment, culture medium was refreshed. Etoposide treatment
(50 lM) was performed continuously every 3 days for 10 days.
Oncogene-induced senescence: human foetal lung IMR90 diploid
fibroblasts were cultured in DMEM (phenol red free) supplemented
with 20% FBS, 100 units ml1 penicillin, 100 lg ml1 streptomycin
and 2 mM glutamine at 37°C in a humidified atmosphere with 5%
CO2 and 3% oxygen in a 3-gas cell culture incubator (Zapf Instru-
ments, Sarstedt, Germany). For ER-RAS induction, ER-RAS-IMR90
cells were supplemented with 100 nM of 4-hydroxytamoxifen
(4-OHT) and maintained in 4-OHT-containing medium until harvest-
ing. Replicative senescence was achieved through replication
exhaustion and confirmed by cells being positive for Sen-b-Gal,
negative for BrdU and Ki67 and performing less than 0.5 population
doublings for at least 4 weeks.
Plasmid transfection and viral infection
For the overexpression of activated Rheb and PGC-1b, MEFs were
transfected with an empty vector and pcDNA3-flag-Rheb-N153T
(Addgene #19997) or pcDNAf:PGC-1b (Addgene #1031) respec-
tively, using LipofectamineTM 2000 (Invitrogen, 11668-019) following
the manufacturer’s instructions. YFP-Parkin retroviral production:
phoenix amphotropic cells were incubated for 24 h in antibiotic-free
medium before proceeding to transfection with a LZRS or LZRS-
YFP_Parkin vector using LipofectamineTM 2000 (Invitrogen, 11668-
019) following the manufacturer instructions. Cells were transduced
with YFP-Parkin retroviral and shPGC-1b lentiviral particles (Santa
Cruz Biotechnology #sc-62783-V) as described in the ViraPower
Lentiviral Expression systems user manual (Invitrogen). All experi-
ments involving virus were performed following class II safety
procedures. Transduction efficiency was confirmed by fluorescence
microscopy, Western blotting and/or qPCR.
RNA sequencing
Samples were sequenced on an Illumina Next Seq. Paired-end reads
were aligned to the human genome (hg19) using the splicing-aware
aligner Tophat2 (Kim et al, 2013). Duplicate reads were identified
using the picard tools (1.98) script mark duplicates (https://github.
com/broadinstitute/picard) and only non-duplicate reads were
retained. Reference splice junctions are provided by a reference tran-
scriptome (Ensembl build 73). FPKM values were calculated using
Cufflinks (Trapnell et al, 2013). Differential genes expression was
called using the cuffdiff (Trapnell et al, 2013) maximum-likelihood
estimate function. Genes of significantly changing expression were
defined as FDR-corrected P-value < 0.05 and at least twofold change.
Only ensembl 73 genes of status “known” and biotype “coding” were
used for downstream analysis.
Reads were trimmed using Trim Galore (v0.3.0) (http://www.
bioinformatics.babraham.ac.uk/projects/trim_galore/) and quality
assessed using FastQC (v0.10.0) (http://www.bioinformatics.
bbsrc.ac.uk/projects/fastqc/).
Venn diagrams
Venn diagrams and associated empirical P-values were generated
using the USeq (v7.1.2) tool IntersectLists (Nix et al, 2008). The
t-value used was 22,008, as the total number of genes of status
“known” and biotype “coding” in ensembl genes 73. The number of
iterations used was 1,000.
RNA-seq heatmaps
For each gene, the FPKM value was calculated based on aligned
reads, using Cufflinks (Trapnell et al, 2013). Z-scores were gener-
ated from FPKMs. Hierarchical clustering was performed using the
R library heatmap.2 and the distfun=“pearson” and hclust-
fun=“average”.
Principal component analysis
Principal component analysis (PCA) was performed using the FPKM
values of all ensembl 73 genes of status “known” and biotype
“coding”.
The RNA-seq data from this publication have been submitted to
the GEO database (http://www.ncbi.nlm.nih.gov/geo/) and
assigned the identifier GSE76125.
Treatment with pathway inhibitors
For mTORC1 inhibition, cells were treated with 100 nM rapamycin
(Sigma, R8781) immediately after the senescence stimuli (X-ray,
neocarzinostatin, H2O2 and etoposide). Cells were collected at dif-
ferent time points after treatments. Replicative senescent MRC5
fibroblasts were treated with 100 nM rapamycin for 10 days before
being harvested for analysis. Rapamycin-supplemented media were
always refreshed 24 h prior to cell collection to avoid starvation
confounding effects on mTORC1 activity.
For ATM inhibition, MRC5 fibroblasts irradiated with 20-Gy
X-ray were treated with 10 lM of the ATM chemical inhibitor
KU55933 (R&D Systems; 3544). Cells were collected at different time
points after treatment.
Antioxidant treatments were performed in cells irradiated with
20-Gy X-ray treated with 2.5 mM NAC (Sigma; A7250) or 400 lM
PBN (Sigma, 180270) immediately after irradiation. The cells were
collected at different times after treatment.
Parkin-mediated mitochondria clearance
Proliferating stably expressing YFP-Parkin human MRC5 fibroblasts
were treated with 12.5 lM CCCP (Sigma; C2759) for 48 h (refreshed
every 24 h). Stably expressing YFP-Parkin human MRC5 fibroblasts
were irradiated with 20-Gy X-ray and treated 2 days after with
12.5 lM CCCP for 48 h (refreshed every 24 h). Stably expressing
YFP-Parkin human MRC5 fibroblasts were treated with 400 lM of
H2O2 for 1 h in serum-free medium and treated 2 days after with
12.5 lM CCCP for 48 h (refreshed every 24 h). Replicative senescent
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YFP-Parkin-MRC5 fibroblasts were treated with 12.5 lM CCCP for
48 h (refreshed every 24 h). Media (no CCCP) was refreshed after
CCCP treatment; the cells were then collected at the indicated time
points for analysis. Oncogene-induced senescence (OIS) experiments
were performed by treating Parkin-expressing IMR-90/ER-RAS
fibroblasts with 12.5 lM CCCP for 48 h, followed by ER-RAS induc-
tion with 100 nM of 4-hydroxytamoxifen (4-OHT). The cells were
harvested at day 7 after ER-RAS induction. Mitochondria-depleted
cells require to be seeded at a cellular density of 60–70%.
Knockdown by small interfering RNA (siRNA)
MRC5 cells were transiently transfected with siRNAs using HiPer-
Fect Transfection ReagentTM (Qiagen, 301707). Cells were trans-
fected with 10 nM siRNA (negative control siRNA, Qiagen—
SI03650325; Hs_FRAP1_4 FlexiTube siRNA, Qiagen—SI00070462;
Hs_FRAP1_6 FlexiTube siRNA, Qiagen—SI02662009) following the
HiPerFect Transfection Reagent Handbook instructions. The cells
were transfected 24 h prior to 20-Gy X-radiation and harvested for
analysis 72 h after transfection (2 days after IR). siRNA transfection
efficiency was assessed by qPCR and/or Western blotting.
Mitochondrial mass and ROS measurements
For mitochondrial mass assessment, cells were stained with 10 lM
of nonyl acridine orange (NAO, Molecular Probes, Invitrogen) for
10 min at 37°C and measured by flow cytometry. Alternatively, the
cells were loaded with MitoTracker green in serum-free medium for
30 min at 37°C and imaged on a Leica DM5500B fluorescence
microscope. Transmission electron microscopy was performed using
conventional techniques, and mitochondrial number and volume
fraction were analysed from 15 to 20 electron micrographs per
animal (n = 3) or human fibroblasts using ImageJ (http://
rsb.info.nih.gov/ij/). mtDNA copy number was measured in human
and mouse fibroblasts by qPCR (primers in Appendix Table S1).
ROS were measured using 10 lM dihydroethidium (DHE), which
detects cellular superoxide levels, or 5 lM MitoSOX (Molecular
Probes, Invitrogen), which detects mitochondrial superoxide levels,
or 10 lM dihydrorhodamine 123 (DHR123), which detects cellular
peroxides. Cells were incubated for 30 or 10 min at 37°C in the
dark, with DHE (5 lM) or MitoSOX (5 lM), respectively, in serum-
free media and analysed by flow cytometry (30,000 cells were anal-
ysed per condition).
Measurements of cellular bioenergetics
Cellular oxygen consumption rates (OCR) and media acidification
rates (extracellular acidification rate, ECAR) were measured in
parallel using a Seahorse XF24 analyzer in unbuffered basic media
supplemented with 5 mM glucose, 2 mM L-glutamate and 3% FBS.
The following compounds were supplemented to test mitochondrial
activity and cellular bioenergetics flux: 0.5 lM oligomycin to inhibit
ATP synthase (hence inhibiting mitochondrial ATP generation),
2.5 lM carbonyl cyanide p-trifluoromethoxy-phenylhydrazone
(FCCP), a respiratory chain uncoupler, 80 mM 2-deoxyglucose
(2DG), a glucose analogue competitively inhibiting glucose uptake
and glycolytic flux, and 0.5 lM rotenone and 2.5 lM antimycin,
mitochondrial complex I and complex III inhibitors, respectively.
ATP production by mitochondria was calculated by multiplying ATP
turnover ((basal OCR) – (OCR with oligomycin) by the established
phosphorus/oxygen (P/O) ratio of 2.3 (Brand, 2005). ATP produc-
tion by glycolysis is considered to have a 1:1 ratio with lactate
production. The extracellular acidification rate is mainly due to
lactate and bicarbonate production and, when calibrated as the
proton production rate, indicates glycolytic rate (Birket et al, 2011;
Wu et al, 2007). Data were normalized to cell number.
Steady-state cellular ATP levels were performed using the ATP
determination Kit (Invitrogen, A22066) following the manufac-
turer’s instructions.
Measurements of OCR in isolated mitochondria
Mouse liver mitochondria were isolated by the method described by
Chappell and Hansford (1972) in medium comprising 0.25 M
sucrose, 5 mM Tris–HCl and 2 mM EGTA (pH 7.4 at 4°C) (STE
buffer). The crude mitochondria were purified by adapting the
method described in Pagliarini et al (2008). Essentially, 0.5 ml of
crude mitochondria (about 30–40 mg ml1) was carefully layered
on top of a stepwise density gradient of 2 ml 80%, 6 ml 52% and
6 ml 26% Percoll in a 50-ml centrifuge tube. The gradient was
centrifuged at 41,100 g for 45 min in a Beckman Coulter Avanti
J-E centrifuge, using a JA-20 rotor. Mitochondria were collected
from the interface of the 26–52% interface, diluted to capacity in a
2-ml microcentrifuge tube with STE buffer and centrifuged at
12,000 g in a refrigerated table top centrifuge for 10 min. The super-
natant was carefully discarded, and the mitochondria were washed
with an additional 2 ml of STE buffer and centrifuged again. The
resulting pellet was resuspended in a small volume of STE buffer for
functional experiments. Mitochondrial oxygen consumption rates
were measured using the Seahorse XF analyzer based on the method
described in Rogers et al (2011), with adjustment explained in the
Comments to the articles published in PLoS online (A source of data
variation in mitochondrial respiration measurements). The mito-
chondria were energized with 5 mM pyruvate and 5 mM malate,
and State III respiration was obtained by adding 4 mM ADP.
Assessment of the SASP
Quantibody Human Cytokine Arrays for 20 cytokines (RayBiotech;
QAH-CYT-1) were performed. Conditioned media were collected
prior to irradiation (time 0) and 3 and 10 days after 20-Gy X-ray
following 24-h serum deprivation. mRNA levels of human IL-6 and
IL-8 and mouse IL-6, CXCL1, CXCL5 and inhibin A were measured
by qPCR (primers in Appendix Table S2). Concentrations of IL-6 and
IL-8 in cell culture media were determined using a sandwich ELISA
(R&D Systems; DY206/DY208) according to the manufacturer’s
instructions. Limits of detection for these assays were 10 pg ml1.
Quantitative real-time PCR
Total RNA was extracted using the RNeasy minikit (QIAGEN,
74106). Complementary DNAs were generated using the Omniscript
RT Kit (Qiagen, 205110) as described on the Omniscript Reverse
Transcription Handbook. Quantitative real-time PCR were
conducted using the Power Syber Green PCR Master Mix (Invitro-
gen, 4367659) in a C1000TM Thermal Cycler, CFX96TM Real-Time
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System (Bio-Rad) and Bio-Rad CXF Manager software. Expression
was normalized to b-actin for mouse or GAPDH for human samples.
Sequences of the primers used are included in the Appendix Table S2.
Immunofluorescence and immuno-FISH
For immunofluorescence, cells grown on coverslips were fixed in
2% paraformaldehyde and incubated with a primary antibody for
1 h at room temperature, followed by either an Alexa Fluor 488,
594 or 647 secondary antibody (Invitrogen) 45-min incubation.
Antibodies used are given in the Appendix Table S3.
For immunofluorescence coupled with telomere-fluorescence
in situ hybridization (immuno-FISH), cells grown on coverslips
were fixed in 2% paraformaldehyde and c-H2A.X immunofluores-
cence staining was performed. Following immunostaining, tissue
sections were washed in PBS and fixed in 4% formaldehyde aque-
ous solution buffered for 20 min. The tissue sections were then
dehydrated with 70, 90 and 100% ethanol solutions. Samples were
denatured for 10 min at 80°C in hybridization buffer [70% deion-
ized formamide, 25 mM MgCl2, 1 M Tris pH 7.2, 5% blocking
reagent (Roche, Welwyn, UK)] containing 4 ng ll1 Cy-3-labelled
telomere-specific (CCCTAA) peptide nucleic acid probe (Panagene,
F1002-5), followed by hybridization for 2 h at room temperature.
The slides were washed for 10 min with 70% formamide in 2× SSC
following by a wash in 2× SSC and a final wash in PBS for 10 min.
Nuclei were counterstained with DAPI, and the sections were
mounted and imaged in a Leica DM5500B fluorescence microscope.
In-depth Z stacking was used (a minimum of 40 optical slices
with 100× objective) followed by Huygens (SVI) deconvolution.
Telomere-associated foci were analysed blinded by 3 analysts.
BrdU and EdU incorporation
BrdU incorporation was performed for 24 h. Cells were fixed in cold
70% ethanol, treated with 1.5 M hydrochloric acid for 30 min and
neutralized with 0.1 M borate buffer for 10 min. Cells were washed
in PBS and BrdU immunostaining was performed (as described
above). EdU incorporation was performed for 24 h prior to the
detection with the Click-IT EdU Alexa Fluor 594 Imaging Kit (Invit-
rogen, C103339) following the manufacturer’s instructions.
Senescence-associated b-galactosidase staining (Sen-b-Gal)
For Sen b-Gal staining, the cells were fixed with 2% paraformalde-
hyde for 5 min and stained as described in Dimri et al (1995). For
liver tissues, Sen b-Gal staining was performed as described in
Baker et al (2011).
Western blotting analysis
Western blotting was performed using conventional techniques.
Primary and secondary antibodies are described in detail in the
Appendix Table S4.
Mice groups, treatments and housing
C57/BL6 mice were split into 2 groups (n = 10/group) according
to age and diet: (i) 15-month-old mice: 3-month-old mice fed with
control or rapamycin diet for 12 months, and (ii) 16-month-old
mice: 12-month-old mice fed with control or rapamycin diet for
4 months. The different mice groups were matched for age and
randomly assigned for the treatments. Control and rapamycin
diets were purchased from TestDiet—control diet: 5LG6/122 PPM
EUDRAGIT 3/8 #1814831 (5AS0) and encapsulated rapamycin
diet: 5LG6/122 PPM ENCAP RAP 3/8 #1814830 (5ARZ). Mice
were fed ad libitum and monitored weekly. PGC-1b/ mice were
generated and provided by Transgenic RAD, Discovery Science,
Astrazeneca. Animals were fed ad libitum on a normal chow diet
(10% of calories derived from fat; D12450B, Research Diets).
Wild-type and PGC-1b/ C57/BL6 mice were sacrificed at
18 months of age.
Animal procedures were performed in accordance with the UK
Home Office regulations and the UK Animal Scientific Procedures
Act [A(sp)A 1986]. Animals were housed in a temperature-
controlled room with a 12-h light/dark cycle. No statistical method
was used to predetermine sample size. No animals or samples were
excluded from the analysis.
Mice tissues collection and preparation
Tissues were collected during necropsy and fixed with either 4%
formaldehyde aqueous solution buffered (VWR; 9713.9010) and
paraffin embedded for histochemical analysis or with glutaralde-
hyde (Sigma, G5882) for T.E.M. (morphometric analysis). Part of
the tissues were also frozen in liquid nitrogen and stored at 80°C
for biochemical analysis.
Statistical analyses
We conducted one-way ANOVA, two-tailed t-test, linear and nonlin-
ear regression analysis test using Sigma Plot v11.0. Normal distribu-
tion and equal variance were assessed using Statistical software
from Sigma Plot vs11.0. Wilcoxon–Mann–Whitney tests were
conducted using IBM SPSS Statistics 19.
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